TG Therapeutics Inc (TGTX)
Current ratio
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Total current assets | US$ in thousands | 317,943 | 168,274 | 330,965 | 611,740 | 149,151 |
| Total current liabilities | US$ in thousands | 53,720 | 53,201 | 65,384 | 87,554 | 84,449 |
| Current ratio | 5.92 | 3.16 | 5.06 | 6.99 | 1.77 |
December 31, 2023 calculation
Current ratio = Total current assets ÷ Total current liabilities
= $317,943K ÷ $53,720K
= 5.92
The current ratio of TG Therapeutics Inc has shown fluctuations over the past five years. As of December 31, 2023, the current ratio stands at 5.92, indicating that the company has $5.92 in current assets for every $1 in current liabilities. This represents a significant improvement compared to the previous year, where the current ratio was 3.16.
In general, a current ratio above 1 is considered healthy, as it suggests that a company can easily cover its short-term obligations. TG Therapeutics Inc's current ratio has consistently been above 1 for the past five years, with the highest ratio observed in 2020 at 6.99.
The substantial increase in the current ratio in 2023 compared to 2022 reflects an increase in current assets relative to current liabilities, indicating improved liquidity and financial health. However, it is essential to further assess the composition of current assets and liabilities to gain a more comprehensive understanding of the company's short-term financial position.
Peer comparison
Dec 31, 2023